Lantern Pharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Lantern Pharma stock has a target of 25, which predicts a 693.65% increase from the current stock price of 3.15.

Price Target: $25 (+693.65%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$25	$25	$25	$25
Change	+693.65%	+693.65%	+693.65%	+693.65%

* Price targets were last updated on Apr 2, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Lantern Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Chad Messer Lake Street	Lake Street	Strong Buy Initiates $25	Strong Buy	Initiates	$25	+693.65%	Apr 2, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 25, 2024
Michael King EF Hutton	EF Hutton	Strong Buy Reiterates $11	Strong Buy	Reiterates	$11	+249.21%	Aug 10, 2023
Michael King EF Hutton	EF Hutton	Strong Buy Maintains $11	Strong Buy	Maintains	$11	+249.21%	Jun 26, 2023
Michael King EF Hutton	EF Hutton	Strong Buy Initiates $11	Strong Buy	Initiates	$11	+249.21%	May 25, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.86

from -1.93

EPS Next Year

-1.58

from -1.86

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-1.37	-1.13	-1.31	-1.47	-1.93	-1.86	-1.58	-1.24
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.90	-1.20	-0.86
Avg	-1.86	-1.58	-1.24
Low	-1.80	-1.92	-1.59

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.